Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03695315 · ClinicalTrials.gov registry record
Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 48
- Enrollment target
NCT03695315 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 48 participants.
The verdict
NCT03695315 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) is a common condition associated with significant adverse health outcomes. Our overarching hypothesis is that patients with OSA and hypoxia (H-OSA) have greater degrees of insulin resistance in both liver and adipose tissue when compared to those without hypoxia (NH-OSA) thus leading to increased risk for the development of diabetes in the former group.
Interventions
- DEVICE Continuous Positive Airway Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-10-31 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03695315
The ClinicalTrials.gov registry entry for NCT03695315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Positive Airway Pressure is the first listed.
NCT03695315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03695315 about?
NCT03695315 is a clinical study titled "Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of Hypoxia". Obstructive sleep apnea (OSA) is a common condition associated with significant adverse health outcomes. Our overarching hypothesis is that patients with OSA and hypoxia (H-OSA) have greater degrees of insulin resistance in both liver and adipose tissue when compared to those without hypoxia (NH-OSA...
What is the current status of trial NCT03695315?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2018-10-31. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT03695315?
The interventions under investigation include: Continuous Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT03695315?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.